Fibrinolytic biomarkers for identifying patients at risk of severe COVID-19
by Juntendo University Research Promotion CenterSignificant decreases in circulating uPA and uPA/PAI-1 complex levels may be a novel biomarker of COVID-19 severity. Credit: Dr. Koichi Hattori/Juntendo
Updated on: March 20,2024
11
Fibrinolytic biomarkers for identifying patients at risk of severe COVID-19
by Juntendo University Research Promotion CenterSignificant decreases in circulating uPA and uPA/PAI-1 complex levels may be a novel biomarker of COVID-19 severity. Credit: Dr. Koichi Hattori/Juntendo
Updated on:March 20,2024
11